Cmpx stock forecast.

Lastly, it’s important to evaluate a stock by comparing it against others in the same industry. Review the table below to see how Compass Therapeutics Inc. stock stands up against its competitors. Click into any of the below tickers to see their stock grades for value, momentum, quality and EPS revisions. Compass Therapeutics Inc. (CMPX ...Find the latest Fusion Pharmaceuticals Inc. (FUSN) stock quote, history, news and other vital information to help you with your stock trading and investing.Compass Therapeutics, Inc. company earnings calendar and analyst expectations - Upcoming and past events | Nasdaq: CMPX | Nasdaq 499661.RZn13_X8zmir-ZmDNDt6CBVpoKyMtbZ8jz_TNs1a5fg.Gu2S5sO-llGbyt-1YUocQSMry9i_gNNR2FnlQIYuibMJrZ6Ip5WHGsaw1ABack to CMPX Overview. *The upcoming earnings date is derived from an algorithm based on a company's historical reporting dates. It is possible that this date will be updated in the future, once ...

Find the latest Capital Power Corporation (CPX.TO) stock quote, history, news and other vital information to help you with your stock trading and investing. ... Performance Outlook. Short Term. 2W ...CMPX Stock predictions, price target today, Technical and Fundamental analysis to buy the best StockThe Mirum Pharmaceuticals, Inc. stock price fell by -2.22% on the last day (Tuesday, 28th Nov 2023) from $32.04 to $31.33. During the last trading day the stock fluctuated 4.28% from a day low at $30.75 to a day high of $32.06. The price has fallen in 6 of the last 10 days but is still up by 2.76% over the past 2 weeks.

The development of new drugs generally has a high failure rate, and such failures may negatively impact the stock price of the company developing the failed ...

Nov 10, 2023 · Website. 2014. 26. Tom Schuetz. https://www.compasstherapeutics.com. Compass Therapeutics, Inc., a clinical-stage oncology-focused biopharmaceutical company, engages in developing antibody-based therapeutics to treat various human diseases. The company’s product candidates include CTX-009, a bispecific antibody that blocks Delta-like ligand 4 ... Watch live market analysis and forecasts, learn new trading strategies, share your ideas and opinions with millions of traders with our streams.Find real-time CIX - CompX International Inc stock quotes, company profile, news and forecasts from CNN Business. According to . 1 Wall Street analyst that have issued a 1 year PSTV price target, the average PSTV price target is $8.00, with the highest PSTV stock price forecast at $8.00 and the lowest PSTV stock price forecast at $8.00.CMPX Stock 12 Months Forecast. $10.50. (510.47% Upside) Based on 2 Wall Street analysts offering 12 month price targets for Compass Therapeutics in the last 3 months. The average price target is $10.50 with a high forecast of $11.00 and a low forecast of $10.00. The average price target represents a 510.47% change from the last price of $1.72.

The development of new drugs generally has a high failure rate, and such failures may negatively impact the stock price of the company developing the failed ...

Top Analysts Based on 1 analyst offering 12 month price targets for Compass Therapeutics Inc. Min Forecast $10.00 +528.93% Avg Forecast $10.00 +528.93% Max Forecast …

View the latest CMPX earnings date, analysts forecasts, earnings history, and conference call transcripts. Skip to main content. S&P 500 4,594.63. DOW 36,245.50. QQQ 389.94. ... Stock Ideas and …Oct 2, 2023 · Future criteria checks 0/6. Compass Therapeutics is forecast to grow earnings and revenue by 21.6% and 76.7% per annum respectively while EPS is expected to grow by 25.3% per annum. 1.57%. $249.05M. CIX | Complete CompX International Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.5 brokers have issued 12 month target prices for Zura Bio's stock. Their ZURA share price targets range from $10.00 to $22.00. On average, they predict the company's stock price to reach $16.60 in the next twelve months. This suggests a possible upside of 257.0% from the stock's current price.The projected low price target is $8.00 while the price target rests at a high of $11.00. In that case, then, we find that the current price level is -618.95% off the targeted high while a plunge would see the stock gain -422.88% from current levels. Compass Therapeutics Inc (CMPX) estimates and forecastsCompass Therapeutics, Inc. company earnings calendar and analyst expectations - Upcoming and past events | Nasdaq: CMPX | Nasdaq 499661.RZn13_X8zmir-ZmDNDt6CBVpoKyMtbZ8jz_TNs1a5fg.Gu2S5sO-llGbyt-1YUocQSMry9i_gNNR2FnlQIYuibMJrZ6Ip5WHGsaw1A

The Meme Stock. C-Suite Advisors. Sign In. ... Nvidia earnings crush forecasts, outlook tops estimates, amid surging AI demand. By Martin Baccardax. Nov 21, 2023 5:00 PM EST. STOCKS. MSFT NVDA.Nov 15, 2023 · The projected low price target is $8.00 while the price target rests at a high of $11.00. In that case, then, we find that the current price level is -618.95% off the targeted high while a plunge would see the stock gain -422.88% from current levels. Compass Therapeutics Inc (CMPX) estimates and forecasts US Stock MarketDetailed Quotes. PEPG PepGen. Close 11/13 16:00 ET. 4.340. +0.480 +12.44%. High 4.762 ... Inc. (PEPG), 4D Molecular Therapeutics (FDMT) and ...Dec 1, 2023 · The consensus price target of analysts on Wall Street is $9.17, which implies an increase of 82.01% to the stock’s current value. The extremes of the forecast give a target low and a target high price of $8.00 and $11.00 respectively. As a result, CMPX is trading at a discount of -566.67% off the target high and -384.85% off the low. Buy a little, but exit at $42.25. (CPX-T) They successfully transitioned from coal to gas and other green energy. An excellent long-term performer, but 27% over 3 years. Was up last year in a down year. (CPX-T) Trevor Rose’s Insights - Trevor’s most-liked answers from 5i Research. Business sensitive to Alberta market.Nov 24, 2023 · The ALX Oncology Holdings Inc. stock price fell by -4.02% on the last day (Friday, 24th Nov 2023) from $9.21 to $8.84. During the last trading day the stock fluctuated 10.18% from a day low at $8.79 to a day high of $9.69. The price has risen in 6 of the last 10 days and is up by 12.76% over the past 2 weeks.

Compass Therapeutics Inc. (CMPX) stock is trading at $3.95 as of 12:48 PM on Tuesday, Jan 31, an increase of $0.10, or 2.6% from the previous closing price of $3.85. The stock has traded between $3.88 and $4.13 so far today. Volume today is less active than usual.We've seen plenty of personal finance tools designed to help you track what you're spending, but web site PocketSmith is an impressive new web-based personal finance tool with an emphasis on forecasting your financial future. We've seen ple...

Are you tired of spending countless hours manually tracking your inventory? Are you looking for a way to improve your decision making and forecasting processes? Look no further than a free inventory tracking template.Stock Price Forecast. The 5 analysts offering 12-month price forecasts for CompoSecure Inc have a median target of 13.00, with a high estimate of 15.00 and a low estimate of 7.00. The median ...According to . 1 Wall Street analyst that have issued a 1 year PSTV price target, the average PSTV price target is $8.00, with the highest PSTV stock price forecast at $8.00 and the lowest PSTV stock price forecast at $8.00.CMPX Stock predictions, price target today, Technical and Fundamental analysis to buy the best StockBased on analysts offering 12 month price targets for CMPX in the last 3 months. The average price target is $ 0.00 with a high estimate of $ 0.00 and a low estimate of $ 0.00 .Stock Price Forecast. According to 4 stock analysts, the average 12-month stock price forecast for CMPX stock stock is $9.33, which predicts an increase of 442.44%. The lowest target is $8.00 and the highest is $10.3. On average, analysts rate CMPX stock stock as a strong buy.CompX International, Inc. engages in the manufacturer of security products used in the recreational transportation, postal, office and institutional furniture, cabinetry, tool stoIn today’s fast-paced business environment, accurate forecasting is crucial for making informed decisions and staying ahead of the competition. One powerful tool that can help you achieve this is a forecasting Excel template.March 7, 2024. EPS forecast (this quarter) $0.30. Annual revenue (last year) $378.5M. Annual profit (last year) $18.7M. Net profit margin.

CMPX Overview Stock Screener Earnings Calendar Sectors Nasdaq | CMPX U.S.: Nasdaq Compass Therapeutics Inc. Watch NEW Set a price target alert After Hours Last Updated: Oct 13, 2023 4:38...

NSD:CMPX Detailed Stock Analysis, Stock Price Forecasts, Analyst Ratings, Financial Analysis, Stock News & Historic Quotes

Compass Therapeutics Inc stocks price quote with latest real-time prices, charts, financials, latest news, technical analysis and opinions. ... The Barchart Technical Opinion rating is a 40% Sell with a Weakest short term outlook on maintaining the current direction. ... CMPX Related stocks. Symbol 3M %Chg ; CMPX +4.67% : Compass Therapeutics ...1.57%. $249.05M. CIX | Complete CompX International Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.Compass Therapeutics Inc. analyst ratings, historical stock prices, earnings estimates & actuals. CMPX updated stock price target summary. Nowadays finding high-quality stock photos for personal or commercial use is very simple. You just need to search the photo using a few descriptive words and let Google do the rest of the work.See the latest Compass Therapeutics Inc Ordinary Shares stock price (NASDAQ:CMPX), related news, valuation, dividends and more to help you make your investing decisions.SOS Limited - ADR Stock Forecast, SOS stock price prediction. Price target in 14 days: 4.203 USD. The best long-term & short-term SOS Limited - ADR share price ... Compass Therapeutics (CMPX) Stock Forecast & Price Prediction. Estimation of the future price movement of Compass Therapeutics stock, based on various factors such as …Nov 24, 2023 · The ALX Oncology Holdings Inc. stock price fell by -4.02% on the last day (Friday, 24th Nov 2023) from $9.21 to $8.84. During the last trading day the stock fluctuated 10.18% from a day low at $8.79 to a day high of $9.69. The price has risen in 6 of the last 10 days and is up by 12.76% over the past 2 weeks. The stock of Compass Therapeutics Inc (CMPX) has gone down by -4.07% for the week, with a -8.33% drop in the past month and a -29.18% drop in the past quarter. The volatility ratio for the week is 4.13%, and the volatility levels for the past 30 days are 7.49% for CMPX. The simple moving […]Nov 23, 2022 · Stock Screener; ETF Screener; Comparisons; Explore Alpha Picks ... Compass Therapeutics (CMPX) Investor Presentation - Slideshow. Nov. 23, 2022 6:22 AM ET Compass Therapeutics, Inc. (CMPX) SA ... Dec 1, 2023 · The stock of Compass Therapeutics Inc (CMPX) has gone down by -4.07% for the week, with a -8.33% drop in the past month and a -29.18% drop in the past quarter. The volatility ratio for the week is 4.13%, and the volatility levels for the past 30 days are 7.49% for CMPX. The simple moving […]

Compass Therapeutics, Inc. (CMPX) NasdaqCM - NasdaqCM Real Time Price. Currency in USD Follow 2W 10W 9M 1.6500 -0.0700 (-4.07%) At close: 04:00PM EST 1.6500 0.00 (0.00%) After hours: 04:20PM EST...The 6 analysts offering 1 year price forecasts for CMPX have a max estimate of — and a min estimate of —. Analyst rating Based on 6 analysts giving stock ratings to CMPX in …Stock Price Forecast. According to 4 stock analysts, the average 12-month stock price forecast for CMPX stock stock is $9.33, which predicts an increase of 442.44%. The lowest target is $8.00 and the highest is $10.3. On average, analysts rate CMPX stock stock as a strong buy.Website. 2014. 26. Tom Schuetz. https://www.compasstherapeutics.com. Compass Therapeutics, Inc., a clinical-stage oncology-focused biopharmaceutical company, engages in developing antibody-based therapeutics to treat various human diseases. The company’s product candidates include CTX-009, a bispecific antibody that blocks Delta-like ligand 4 ...Instagram:https://instagram. vision insurance georgiazero spread brokersbxp tickerelectra meccanica stock News Ideas Financials Technicals Forecast CMPX chart Today 2.59% 5 days 2.06% 1 month 3.66% 6 months −31.25% Year to date −61.10% 1 year −34.44% 5 years −76.71% All time −76.71% Key stats Market capitalization 252.37M USD Dividends yield (FY) — Price to earnings Ratio (TTM) — Basic EPS (TTM) −0.37 USD Net income −39.225M USD Revenue — Shares float ev stocks to watch1964 silver fifty cent piece value The value each CMPX share was expected to gain vs. the value that each CMPX share actually gained. Compass Therapeutics ( CMPX) reported Q2 2023 earnings per share (EPS) of -$0.09, missing estimates of -$0.08 by 9.30%. In the same quarter last year, Compass Therapeutics 's earnings per share (EPS) was -$0.08. Compass Therapeutics is expected to ...Track COMPASS Pathways (CMPS) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investors top ai stocks to invest in Find the latest Immunovant, Inc. (IMVT) stock quote, history, news and other vital information to help you with your stock trading and investing.The consensus price target of analysts on Wall Street is $2.50, which implies an increase of 83.2% to the stock’s current value. The extremes of the forecast give a target low and a target high price of $2.50 and $2.50 respectively. As a result, VGZ is trading at a discount of -495.24% off the target high and -495.24% off the low.Are you tired of spending countless hours manually tracking your inventory? Are you looking for a way to improve your decision making and forecasting processes? Look no further than a free inventory tracking template.